Glycemic effects of simvastatin: Where do we stand?

• Auteurs principaux: Nor Razida Razali (Auteur), Hasniza Zaman Huri (Auteur), Luqman Ibrahim (Auteur), Shireene Ratna Vethakkan (Auteur), Bashar Mudhaffar Abdullah (Auteur)
• Format: Livre
• Publié: Universidade de São Paulo, 2018-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

ABSTRACT In clinical practice, simvastatin is usually used in the treatment of dyslipidemia patients and those at risk of or with established cardiovascular disease. However, previous studies have shown that simvastatin has the potential to affect glycemic parameters as it reportedly reduced insulin...